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We are pleased to rece ive Letters to the Edi tor on appropr iate subjects. These l et~e rs should be submi tted 
in typewritten form, double-spaced, and are not to exceed 2 '/• pages. When appropnate, we will soiic1t com-
ments from the or ig in a l a u thors. A ll Letters to t he Edt tor are subject to ed1 t m g a nd poss tble abndgmen t . 
REGENERATION OF AXILLARY HAIR 
To the Editor: 
The article by Masumi Inaba et al (H istologic Study of the Regen-
eration of Axillary Hair after Removal with S ubcutaneous T issue 
S haver, J Invest Dermatol 72:224-231, May, 1979) contains such a 
conglomerate of mis information that I must not let it go unchaUenged . 
T his is a retrospective s tudy in which the authors conclude that after 
a ll hair fo llicles and sweat glands had been shaved fro m the unders ide 
of the axillary skin new hair " regrew" from the remnant outer sheath, 
when sebaceous glands were preserved, i.e., when the upper portion of 
the fo llicular isthmus was in tact. 
T he authors assure us that their technique of "subcutaneous shav-
ing" removed a ll traces of cutaneous appendages. B ut, how do they 
know? T hey state a irily that specimens "removed immediately after 
shave surgery" showed that they had done their job cleanly. B ut, how 
could they reach this concl usion when they had no information on the 
rest of the "shaved" skin? T hey speak about the underside of the 
axillary epidermis as if it were flat and that the razor severed all 
foll icles and sebaceous glands at the same level. T hey surveyed histo-
logical sections, said to be seria lly cut, removed from 11 patients 6 to 12 
mo after the "operation," when the areas were reopened to tidy up scar 
tissue and to remove cysts. Is it possible to know 6 to 12 rna late r ti·om 
what original t issue the " new" hair germs grew? (The natul'e of this 
materia l naturally limits the number of specimens ava ilab le to the 
authors.) And is it in the interest of science to make such claims? T he 
a uthors could s imply have described wha t they saw. T hose of us who 
have rev iewed the literatUTe dealing with the a lleged new formation of 
hair have fo und that the various asser tions, except for those regarding 
the velvet on cervid antlers, are not substantiated. All assertions of new 
growth al'e conjectural. To bolster their claims, the authors refer to 
Oliver's work (J Embryo) Exp Morpho) 15:331-347, 1966) , bu t this 
comparison is inappropr iate since Oliver was dealing wi th vibrissa! 
fo llicles of rats. Furthermore, Oliver has since discovered that the 
mesenchymal t issue surrounding the lower third of the follicles is 
essentia lly papillary substa nce, and that it is from this tissue that new 
papillae grow when the original ones have been destroyed (personal 
communication). 
Finally, it is a neat trick t:o reconstruct in tissue the events that have 
occurred during the preceding 6 to 12 mo. And, on the assumption that 
the authors chose their very bes t sections to illustrate their findings, I 
conclude that the quali ty of ma teria l they investigated was poor. A 
point of such magni tude as neoformation of ha ir in human skin deserves 
more convincing, if not more elegant testimony. 
William Monta gna 
REPLY 
T he authors are most grateful for P rofessor Montagna's comments. 
As a direct result of our deve lopment of the subcutaneous shaving 
techniq ue for treatment of hircismus and hyperhidrosis, we began to 
quest ion the accepted theory of the development of the hair; when we 
observed the regrowth of s trong hairs. We accordingly developed a 
cellophane tape method for obtaining thick, even sections (200-300 f.L ) 
from paraffin embedded tissue, which can be stained and examined 
under the light microscope in toto, but which are d ifficult to photograph 
for publication . It is impossible to j udge the quali ty of the material 
from black-and-white illustrations, but the observation of the t issue 
under the microscope is convincing, if perhaps not elegant. 
In 10 patients , in biopsies obta ined immediate ly after shaving, it was 
confirmed that both the lower fo llicle and lower permanent portion 
. had in fact been removed by our shaving technique. Nevertheless, we wi t~essed r~generation of axillal'y hair. T he objection that we had no 
information on the rest of the shaved skin is not va lid for 2 reasons. In 
men, where sebaceous glands were purposely left behind, regeneration 
of strong h airs was % to '!" t he number before operation in 10 of 12 
cases while in women, where shaving was done to achieve remova l of seba~eous glands plus the lower portion of hair follicle and apocrine 
gland 44 of 70 had hal'dJy any regeneration after 5 months. T his 
number , however, decreased to 15 of 50 after 24 mo. It seems unlikely 
that the original hair bulb would stay dormant for such a long period 
if it was present. Removal of the t ransient portion of the hair fo llicles 
is moreover easily confumed by inspecting the lower su rface of th e skin 
after everting it through the incis ion immediate ly after operation. All 
t hese facts were documented in the Journal of Dermatological S urgery 
and Oncology, vol. 4, pp 921-926, 1978. 
Again, our resem·ch on epilation by electrocoagulation revealed t hat 
when the upper isthmal portion and sebaceous gland (middle port ion , 
according to H . P inkus) are completely destroyed, regeneration of hair 
cannot occul'. (J Derm atol S u.rg Oneal 5:407-4 11, 1979). 
Studies performed subsequently to the present paper and submitted 
for publication have a U suggested that new ha ir is formed in a specific 
region in the upper por tion of the isthmus of the follicle. 
AU of our studies to th e present date h ave cast doub t on th e accepted 
theory of development an d regeneration of the ha ir of the human 
(Japanese) axilla. 
We now in tend to extend our research to determine if t he same 
process of hair growth and regeneration occurs in the instance of scalp 
ha ir. 
Masumi Ina ba, MD 
T LYMP HOCYT E DEFECT IN PSOHIASIS 
To the Editor: 
Stimula ted by the recent paper by Har per et a l [1] we would like to 
st~ess cont roversial opinions on lymphocyte function in patients with 
psoriasis. T he number of T lymphocytes, lymphocyte response to 
mitogens, and in tensity of experimental DN CB sensit ization were found 
to be decreased by some a uthors [2-4], whereas normal T cell coun t 
and lymphocyte transformation were detected by others [5-6]. S imi-
lm·ly, PUV A treatment was found to inhibit lymphocyte function in 
some reports [7-8], or to induce no changes in lymphocyte transfor-
mation wi th mi togens by others [1-6]. 
Our data pm·tia lly published in the Jo urnal of Investigative Der-
matology have shown an inverse relationship between both E rosette 
formation [3] or experimental DNCB sensitization [4], and the activity 
of psoriatic lesions but not their extent. In addition, a complete resto-
ra tion of cell-mediated imm unity (CMI) was shown in patients fTee of 
skin lesions [3,9]. In our studies on the effect of PUV A on ce ll -mediated 
immunity (CMI) [8] we have found a t ransit ional inhibi t ion of E rosette 
fo rmation as eal'!y as 1 hr after PUV A exposure: the inhibi t ion lasted 
fo r at least 24 hr. This inhibitory effect of P UVA exposuJ·e disappeared 
and E rosette formation becam e completely normal slaTting fro m 9-12 
exposures to PU VA (3-4 weeks of photochemotherapy). 
T hus, normal T lymphocyte funct ion in psoriasis is observed in 
patients with stational'y lesions, in the remission, and after longer 
periods of photochemotherapy. 
One could understand reading the paper by Harper et a l [1] that the 
function of T lymphocytes in psoriasis is absolutely normal, but one 
could not in terpret that there is no effect of P UVA on the lymphocytes 
elUTing the ma intenance therapy. T hese authors have studied patients 
free of psoriatic lesions in the 6-30 rna of main tenance PU VA therapy, 
whose blood was drawn 72 hr after the last PUV A exposure. According 
to our experience in such patients norma l CHI should be expected. 
In conclusion, the defect of CMI in psoriasis is only mMginal; it 
seems to be a t ra nsitional and secondm·y phenomenon re lated to disease 
ac tivity, and it is disclosed only when the numerous groups of clinically 
selected patients m·e studied. This may accoun t for divergent findings 
reported in the literature. 
Wieslaw Glinski , M .D . 
Stefania J ablonska, D .D. 
Depal'tment of Dermatology 
Academy of M edicine 
02008 Warsaw, Poland 
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REPLY 
To the Editor: 
Drs. Glinski and Jablonska's letter illustrates the confusion that 
exists concerning the effect of methoxsalen photochemotherapy on 
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lymphocyte function in vivo. I will not add to this confus ion in t his 
forum; however, I would like to emphasize the fo llowing points: 
l. Ou1· study was designed to ascertain any defects in T -lymphocyte 
function in psoriatics who had undergone long-term. methoxsalen pho-
tochemotherapy . OuT experiments were not designed to measm e any 
short-term accuLe effects that the therapy migh t induce. We at tempted 
to see if long-term methoxsalen phoLochemotherapy indu ces lympho-
cyte abnormali ties in vivo. 
2. Our study makes no attempt to compare T -ly mphocyte function 
between untreated-psoriatic patients and normal healthy ind ividua ls. 
Hence, this poin t was not discussed in our paper. 
3. Drs. Glinski and Jablonski sLate that s ince t he patie nts in our 
paper were on main tenance therapy and free of active psoriatic lesions, 
they would have expected normal ce ll mediated immunity. This rea-
soning excludes the possibili ty Lhat long-te rm methoxsalen photochem-
otherapy could induce systemic abnormalities. It would be presump-
tuous to assume that cell mediated immunity hou ld be normal in these 
patients s imply because they have inactive disease. 
4. It should be noted that our paper was in press at the t ime Drs. 
Glinski and J a blonska's paper apperu·ed in print; therefore, we had no 
opportu nity to consider their resu lts in the writing of our paper. 
I believe that in the ligh t of documented evidence s howing a dramatic 
increase in basal and squa mous cell cru·cinoma in psoriatic patients 
undergoing methoxsalen phot.ochemotherapy, t he possibility exists that 
long-term methoxsalen photochemotherapy could lead to syst.e•n ic 
abnormalities. 
Robert A. Hru·per, Ph.D. 
Associate Professor of Dermatology and Biochemistry 
Skin and Cancer Hospital 
Templ.e University School of Med icine 
Philadelphia, Pennsylvania 19140 
